Assessment of the lymphocyte repertoire in relapsing-remitting multiple sclerosis patients treated with ocrelizumab: the ImmunoReMS study

被引：0
|
作者：
Esposito, Federica [1 ,2 ]
Ferre, Laura [1 ,2 ]
Mascia, Elisabetta [2 ]
Sorosina, Melissa [2 ]
Clarelli, Ferdinando [2 ]
Santoro, Silvia [2 ]
Giordano, Antonino [1 ,2 ]
Cannizzaro, Miryam [1 ,2 ]
Moiola, Lucia [1 ]
Martinelli, Vittorio [1 ]
Filippi, Massimo [3 ,4 ,5 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Div Neurosci, Lab Human Genet Neurol Disorders, INSPE, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Neurol & Neurorehabil Unit, Milan, Italy
[4] IRCCS San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit, INSPE, Milan, Italy
[5] Univ Vita Salute San Raffaele, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1285/1895
引用
收藏
页码：815 / 815
页数：1
相关论文
共 50 条
  • [1] Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study
    de Antonio, Luis A. Rodriguez
    Cuberta-Gonzalez, Ines
    Garcia-Castanon, Inmaculada
    Oreja-Guevara, Celia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
  • [2] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [3] Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
    Roos, Izanne
    Hughes, Stella
    McDonnell, Gavin
    Malpas, Charles B.
    Sharmin, Sifat
    Boz, Cavit
    Alroughani, Raed
    Ozakbas, Serkan
    Buzzard, Katherine
    Skibina, Olga
    van der Walt, Anneke
    Butzkueven, Helmut
    Lechner-Scott, Jeannette
    Kuhle, Jens
    Terzi, Murat
    Laureys, Guy
    Van Hijfte, Liesbeth
    John, Nevin
    Grammond, Pierre
    Grand'Maison, Francois
    Soysal, Aysun
    Jensen, Ana Voldsgaard
    Rasmussen, Peter Vestergaard
    Svendsen, Kristina Bacher
    Barzinji, Ismael
    Nielsen, Helle Hvilsted
    Sejbaek, Tobias
    Prakash, Sivagini
    Stilund, Morten Leif Munding
    Weglewski, Arkadiusz
    Issa, Nadia Mubder
    Kant, Matthias
    Sellebjerg, Finn
    Gray, Orla
    Magyari, Melinda
    Kalincik, Tomas
    MSBase Study Grp
    Danish MS Registry Study Grp
    JAMA NEUROLOGY, 2023, 80 (08) : 789 - 797
  • [4] Switching from natalizumab to ocrelizumab in patients with relapsing-remitting multiple sclerosis
    Van Lierop, Z.
    Toorop, A.
    Willemse, E.
    Strijbis, E.
    Kalkers, N.
    Moraal, B.
    Barkhof, F.
    Teunissen, C.
    Killestein, J.
    Van Kempen, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 310 - 311
  • [5] Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis
    Hartung, Hans-Peter
    Benedict, Ralph H. B.
    Berger, Thomas
    Bermel, Robert A.
    Brochet, Bruno
    Carroll, William M.
    Freedman, Mark S.
    Holmoy, Trygve
    Karabudak, Rana
    Nos, Carlos
    Patti, Francesco
    Perrin Ross, Amy
    Vanopdenbosch, Ludo
    Vollmer, Timothy
    Wuerfel, Jens
    Clinch, Susanne
    Kadner, Karen
    Kuenzel, Thomas
    Kulyk, Inessa
    Raposo, Catarina
    Thanei, Gian-Andrea
    Killestein, Joep
    NEUROLOGY, 2024, 103 (12)
  • [6] Evaluation of shorter infusion times with ocrelizumab in patients with relapsing-remitting multiple sclerosis
    Vollmer, Timothy
    Alvarez, Enrique
    Nair, Kavita
    Cohen, Jeffrey
    Boster, Aaron
    Masterman, Donna
    Pradhan, Ashish
    Musch, Bruno
    Ma, Xiaoye
    Pei, Jinglan
    Moss, Brandon
    Weinstock-Guttman, Bianca
    Bermel, Robert
    NEUROLOGY, 2019, 92 (15)
  • [7] Progressive multifocal encephalopathy in the first patient with relapsing-remitting multiple sclerosis treated with ocrelizumab
    Puig Casadevall, M.
    Alvarez Bravo, G.
    Coll-Martinez, C.
    Quiroga-Varela, A.
    Robles-Cedeno, R.
    Gonzalez del Rio, M.
    Salavedra-Pont, J.
    Miguela, A.
    Gich, J.
    Ramio-Torrenta, L.
    Boix-Lago, A.
    Laguillo-Sala, G.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 679 - 680
  • [8] Lymphocyte subpopulation in patients with relapsing-remitting multiple sclerosis and SPMS
    Belniak, E.
    Bojarska-Junak, A.
    Mitosek-Szewczyk, K.
    Bartosik-Psujek, H.
    Stehmasiak, Z.
    Rolinski, J.
    MULTIPLE SCLEROSIS, 2007, 13 : S43 - S43
  • [9] The incidence of infusion associated reactions in Ocrelizumab-treated Relapsing-Remitting Multiple Sclerosis patients.
    Bewick, C.
    Das, E.
    Collins, J.
    Nash, C.
    Fisniku, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 684 - 684
  • [10] Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis
    Algahtani, Hussein
    Shirah, Bader
    Alqahtani, Abdulhadi
    Abdelghaffar, Nawal
    Makki, Samiah
    ACTA NEUROLOGICA BELGICA, 2024, 124 (01) : 303 - 306
12345